Previous studies described CD4+CD8+ cells as effector anti‐tumor T cells in a series of tumors for example, cutaneous T‐cell lymphoma,47, 48 nodular lymphocyte‐predominant Hodgkin lymphoma,49 and melanoma.48 This evidence concerns the gene CD8A and melanoma.